JNM Podcast Episode 3: Alpha is More Than Just Ac-225: Pb-212
This month's episode of the JNM Podcast takes the discussion of Pb-212 worldwide! Researchers from the UK, Australia, and North America discuss the logistics of using lead-212 as a radionuclide imaging agent. From availability to production to transportation, Pb-212 presents both great opportunities and great challenges. Moderator Ken Herrmann, MD, leads this intercontinental panel in a discussion about other radionuclides and their pros and cons. He's joined by David Bauer, PhD, from Memorial Sloan Kettering Cancer Center, Jane Sosabowski, BSc, MSc, PhD, from Queen Mary, University of London, and Nick Fletcher, PhD, from the University of Queensland, Australia.

▶︎
2023 Lead-203/212 Virtual Seminar Series - DOE Isotope Program

▶︎
JNM Podcast Episode 1: The Future of FAPI Therapy

▶︎
SAT12: Going Nuclear - Big Pharma's Radioactive Ambition

▶︎
Dr. Glen Jeffery: Using Red Light to Improve Your Health & the Harmful Effects of LEDs

▶︎
Why Returning From Mars Is Impossible: Feynman's Warning

▶︎
225-Actinium production at TRIUMF: combining physics, engineering, and chemistry for medicine

▶︎
Clinical Quantification of Myocardial Blood Flow Using PET

▶︎
Bioelectricity, Morphogenesis, and Two-Headed Worms | Michael Levin

▶︎
Spine Surgeon Drowns for 30 Minutes —Comes Back With a List

▶︎
How Dopamine & Serotonin Shape Decisions, Motivation & Learning | Dr. Read Montague

▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

▶︎
Introduction to the Physics of Nuclear Medicine (Part 1 of 3)

▶︎
4. 203Pb/212Pb Image-guided alpha therapy for cancer. Progress and Metrology Challenges

▶︎
SAT 01: Amyloid PET in Early Alzheimer’s Disease: Practical Interpretation, Quantification, and...

▶︎
3S for MRI — Scanners, Sequences and Safety

▶︎
Heavy Metal Therapy: Realising the potential of ²¹²Pb targeted alpha therapies

▶︎
Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!

▶︎
CNS Infections | Clinical Medicine

▶︎
JNM Podcast Episode 4: The Standard of Care for Metastatic Prostate Cancer

▶︎
